Dolutegravir, an essential antiretroviral medication primarily used in the treatment of HIV-x infection, is expected to experience a slight price increase in India in March xxxx. This follows a significant price drop in February this year.
Key Takeaways
-
Dolutegravir prices in India are predicted to rise in March xxxx.
-
Increased demand for Dolutegravir, both domestically and internationally, is driving the price adjustment.
-
A potential tariff hike on exports, especially from India, is contributing to higher prices.
-
A slowdown in private sector manufacturing and a weakening Indian Rupee are further influencing price increases.
As per 果酱视频, the February xxxx price of Dolutegravir stood at INR xx,xxx,xxx and predicted a slight hike of x.xxx for March. This price change prediction follows a chain of economic and industry-related circumstances that have been affecting the market.
One of the major causes of this price revision of Dolutegravir is the rise in demand,...
